MUJI 0.5 mm Gel Ink Pen Set – Black (Pack of 6)

Product Information

Do not use Ozempic ® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Treatment with semaglutide 2 mg resulted in a statistically superior reduction in HbA 1c after 40 weeks of treatment compared to semaglutide 1 mg. The kit also contains instructions for use, information on the Cornerstones4Care free support program supported by Novo Nordisk, and an Ozempic savings card. Your Ozempic pen should be stored in the refrigerator (between 36°F to 46°F or 2°C to 8°C) until the first time you use it. After you use it the first time, you can keep it at room temperature or in the refrigerator. Either way, dispose of the pen after 56 days, even if it still contains medication. Body weight has an effect on the exposure of semaglutide. Higher body weight results in lower exposure; a 20% difference in body weight between individuals will result in an approximate 16% difference in exposure. Semaglutide doses of 0.5 mg and 1 mg provide adequate systemic exposure over a body weight range of 40–198 kg.

In fertility studies in rats, semaglutide did not affect mating performance or male fertility. In female rats, an increase in oestrous cycle length and a small reduction in corpora lutea (ovulations) were observed at doses associated with maternal body weight loss. Postnatal growth and development were evaluated in cynomolgus monkeys. Infants were slightly smaller at delivery, but recovered during the lactation period.

If the dose counter stops before you reach your prescribed dose, there is not enough wegovy left for a full dose. Dispose of the pen and use a new wegovy FlexTouch pen.

In addition, a phase 3b trial (SUSTAIN 7) including 1 201 patients was conducted to compare the efficacy and safety of semaglutide 0.5 mg and 1 mg once weekly to dulaglutide 0.75 mg and 1.5 mg once weekly, respectively. A phase 3b trial (SUSTAIN 9), was conducted to investigate the efficacy and safety of semaglutide as add-on to SGLT2 inhibitor treatment. If it stops at 0.25, there is at least 0.25 mg left in your pen. If the dose counter stops before 0.25 mg, there is not enough Ozempic in your pen for a full 0.25 mg dose Age had no effect on the pharmacokinetics of semaglutide based on data from phase 3a studies including patients of 20–86 years of age. Semaglutide caused a minor delay of early postprandial gastric emptying, thereby reducing the rate at which glucose appears in the circulation postprandially. Treatment with semaglutide demonstrated sustained, statistically superior and clinically meaningful reductions in HbA 1c and body weight for up to 2 years compared to placebo and active control treatment (sitagliptin, insulin glargine, exenatide ER and dulaglutide).Your doctor or pharmacist may be able to supply you with a free 6-week starter kit for Ozempic. Each box will contain one prefilled, disposable pen with 2 mg/1.5 mL (1.34 mg/mL) of Ozempic and 6 NovoFine Plus 32 gauge disposable needles.